JSPR - Jasper Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

JSPR is currently covered by 7 analysts with an average price target of $28.77. This is a potential upside of $26.44 (1134.76%) from yesterday's end of day stock price of $2.33.

Jasper Therapeutics's activity chart (see below) currently has 36 price targets and 50 ratings on display. The stock rating distribution of JSPR is 87.5% BUY and 12.5% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 1.59% with an average time for these price targets to be met of 50.33 days.

Highest price target for JSPR is $7, Lowest price target is $4, average price target is $5.67.

Most recent stock forecast was given by SILVAN TUERKCAN from JMP on 21-Sep-2025. First documented stock forecast 13-Oct-2021.

Currently out of the existing stock ratings of JSPR, 14 are a BUY (87.5%), 2 are a HOLD (12.5%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$6

$3.63 (153.16%)

$12

1 months 6 days ago
(21-Sep-2025)

0/6 (0%)

$3.46 (136.22%)

Buy

$7

$4.63 (195.36%)

1 months 6 days ago
(21-Sep-2025)

0/2 (0%)

$4.46 (175.59%)

Hold

$4

$1.63 (68.78%)

$15

3 months 20 days ago
(07-Jul-2025)

0/2 (0%)

$0.98 (32.45%)

Buy

3 months 21 days ago
(06-Jul-2025)

0/7 (0%)

$45.1 (226.63%)

Buy

$80

5 months 13 days ago
(14-May-2025)

0/2 (0%)

$53.3 (199.63%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is JSPR (Jasper Therapeutics) average time for price targets to be met?

On average it took 50.33 days on average for the stock forecasts to be realized with a an average price target met ratio 1.59

Which analyst has the current highest performing score on JSPR (Jasper Therapeutics) with a proven track record?

JUDAH FROMMER

Which analyst has the current lower performing score on JSPR (Jasper Therapeutics) with a proven track record?

KOSTAS BILIOURIS

Which analyst has the most public recommendations on JSPR (Jasper Therapeutics)?

Judah Frommer works at MORGAN STANLEY and has 7 price targets and 4 ratings on JSPR

Which analyst is the currently most bullish on JSPR (Jasper Therapeutics)?

Michael King with highest potential upside - $66.13

Which analyst is the currently most reserved on JSPR (Jasper Therapeutics)?

Jay Olson with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?